Chemical Formula: C31H46O3

Chemical Formula C31H46O3

Found 35 metabolite its formula value is C31H46O3

Vitamin K1 2,3-epoxide

(1aS,7aR)-1a-methyl-7a-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1aH,2H,7H,7aH-naphtho[2,3-b]oxirene-2,7-dione

C31H46O3 (466.3447)


Vitamin K1 2,3-epoxide (CAS: 25486-55-9) is a vitamin K derivative. Vitamin K is needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, vitamin K undergoes electron reduction to a reduced form of vitamin K (called vitamin K hydroquinone) by the enzyme vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes vitamin K hydroquinone to allow carboxylation of glutamate into gamma-carboxyglutamate (Gla). This enzyme is called the gamma-glutamyl carboxylase or the vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize vitamin K hydroquinone into vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted into vitamin K by the vitamin K epoxide reductase. These two enzymes comprise the so-called vitamin K cycle. One of the reasons why vitamin K is rarely deficient in a human diet is because vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency (PMID: 12384421). Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of the coumarin-like activity of drugs (PMID: 2401753). Vitamin K1 2,3-epoxide is a vitamin K derivative. Vitamin K needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, Vitamin K undergoes electron reduction to a reduced form of Vitamin K (called Vitamin K hydroquinone) by the enzyme Vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes Vitamin K hydroquinone to allow carboxylation of Glutamate to Gamma-cabroxygluatmate (Gla); this enzyme is called the gamma-glutamyl carboxylase or the Vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize Vitamin K hydroquinone to vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted to Vitamin K by the Vitamin K epoxide reductase. These two enzymes comprise the so-called Vitamin K cycle. One of the reasons why Vitamin K is rarely deficient in a human diet is because Vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency. (PMID 12384421) Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of coumarin-like activity of drugs. (PMID 2401753) [HMDB]

   

omega-Hydroxyphylloquinone

2-[(E)-16-hydroxy-3,7,11,15-tetramethylhexadec-2-enyl]-3-methylnaphthalene-1,4-dione

C31H46O3 (466.3447)


   

2,3-Epoxyphylloquinone

Naphth[2,3-b]oxirene-2,7-dione, 1a,7a-dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-phylloquinone oxide

C31H46O3 (466.3447)


Vitamin K1 2,3-epoxide is a vitamin K derivative. Vitamin K needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, Vitamin K undergoes electron reduction to a reduced form of Vitamin K (called Vitamin K hydroquinone) by the enzyme Vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes Vitamin K hydroquinone to allow carboxylation of Glutamate to Gamma-cabroxygluatmate (Gla); this enzyme is called the gamma-glutamyl carboxylase or the Vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize Vitamin K hydroquinone to vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted to Vitamin K by the Vitamin K epoxide reductase. These two enzymes comprise the so-called Vitamin K cycle. One of the reasons why Vitamin K is rarely deficient in a human diet is because Vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency. (PMID 12384421) Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of coumarin-like activity of drugs. (PMID 2401753) [HMDB]

   

Corticatic acid E

(-)-Corticatic acid E

C31H46O3 (466.3447)


   

Enervosanone

Enervosanone

C31H46O3 (466.3447)


   
   

24-Methylen-3-oxo-lanosta-7,9(11)-dien-21-saeure|3-oxo-eburica-7,9(11),24(28)-trien-21-oic acid|3-Oxo-eburica-7,9(11),24(28)-trien-21-saeure|7.11-Didehydro-eburiconsaeure|dehydroeburicoic acid|dehydroeburiconic acid

24-Methylen-3-oxo-lanosta-7,9(11)-dien-21-saeure|3-oxo-eburica-7,9(11),24(28)-trien-21-oic acid|3-Oxo-eburica-7,9(11),24(28)-trien-21-saeure|7.11-Didehydro-eburiconsaeure|dehydroeburicoic acid|dehydroeburiconic acid

C31H46O3 (466.3447)


   

Toxistylide B

Toxistylide B

C31H46O3 (466.3447)


   

Maragenin-II-acetat

Maragenin-II-acetat

C31H46O3 (466.3447)


   

5-Monohydroxy-phyllochinon (5-HOK)

5-Monohydroxy-phyllochinon (5-HOK)

C31H46O3 (466.3447)


   

balansinone|rel-(8S,9S,11R,13R,14S,17R,20S,22R,24S)-22-hydroxy-9,11-epoxy-24-methyl-9(10?19)abeo-lanost-25(10),25-trien-1-one

balansinone|rel-(8S,9S,11R,13R,14S,17R,20S,22R,24S)-22-hydroxy-9,11-epoxy-24-methyl-9(10?19)abeo-lanost-25(10),25-trien-1-one

C31H46O3 (466.3447)


   

(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-24a,24b-dihomo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol

(17Z)-1α,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomovitamin D3 / (17Z)-1α,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomocholecalciferol

C31H46O3 (466.3447)


   

Commikuanoid A

21alpha-methoxy-21,23alpha-epoxy-cycloart-1,24-diene-3-one

C31H46O3 (466.3447)


   

Commikuanoid C

21beta-methoxy-21,23beta-epoxy-cycloart-1,24-diene-3-one

C31H46O3 (466.3447)


   

(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomovitamin D3

(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-24a,24b-dihomo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol

C31H46O3 (466.3447)


   

2,3-epoxyphylloquinone

7a-methyl-1a-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1a,7a-dihydronaphtho[2,3-b]oxirene-2,7-dione

C31H46O3 (466.3447)


   

(2-FLUOROPHENYL)THIO]ACETICACID

(2-FLUOROPHENYL)THIO]ACETICACID

C31H46O3 (466.3447)


   

Phytonadione epoxide, (E,2S,3R)-

Phytonadione epoxide, (E,2S,3R)-

C31H46O3 (466.3447)


   

Vitamin K epoxide

Vitamin K epoxide

C31H46O3 (466.3447)


   

Epoxyphylloquinone

Epoxyphylloquinone

C31H46O3 (466.3447)


   

(1s,5r,7r)-1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

(1s,5r,7r)-1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C31H46O3 (466.3447)


   

(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)


   

2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)


   

(4as,6ar,6bs,13bs,15ar,15bs)-4,4,6a,8a,13b,15b-hexamethyl-1h,2h,3h,4ah,5h,6h,6bh,7h,8h,13h,13ah,14h,15h,15ah-indeno[2,1-a]chrysene-9,10,12-triol

(4as,6ar,6bs,13bs,15ar,15bs)-4,4,6a,8a,13b,15b-hexamethyl-1h,2h,3h,4ah,5h,6h,6bh,7h,8h,13h,13ah,14h,15h,15ah-indeno[2,1-a]chrysene-9,10,12-triol

C31H46O3 (466.3447)


   

(3s,4ar,6ar,6bs,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

(3s,4ar,6ar,6bs,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

C31H46O3 (466.3447)


   

5-(2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}propyl)-3,4-dimethyl-5h-furan-2-one

5-(2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}propyl)-3,4-dimethyl-5h-furan-2-one

C31H46O3 (466.3447)


   

2-[(2e,5s,7r,11r)-5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl]-3-methylnaphthalene-1,4-dione

2-[(2e,5s,7r,11r)-5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl]-3-methylnaphthalene-1,4-dione

C31H46O3 (466.3447)


   

2-(5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl)-3-methylnaphthalene-1,4-dione

2-(5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl)-3-methylnaphthalene-1,4-dione

C31H46O3 (466.3447)


   

(27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

(27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

C31H46O3 (466.3447)


   

4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

C31H46O3 (466.3447)


   

(5s)-5-[(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-3,4-dimethyl-5h-furan-2-one

(5s)-5-[(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-3,4-dimethyl-5h-furan-2-one

C31H46O3 (466.3447)


   

29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

C31H46O3 (466.3447)


   

(4z,17z,20z,27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

(4z,17z,20z,27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

C31H46O3 (466.3447)


   

2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-5-methylideneheptanoic acid

2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)


   

2-[(1r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

2-[(1r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)